Trials / Completed
CompletedNCT01142648
Sugammadex and Brain Waves
The Effect of Sugammadex of EEG-derived Index Values
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Tampere University Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
According to our experience, electroencephalogram-based indices of anaesthetic state show elevated numbers after administration of sugammadex (new reversal of neuromuscular blockade). This can be due to altered anaesthetic state, or some kind of artefact. In this study, the phenomenon is evaluated in detail.
Detailed description
Rocuronium-induced neuromuscular blockade is antagonized with sugammadex or neostigmine. BIS, Entropy and the biosignal collected from the Entropy strip are collected on computer. The behaviour of these parameters before, during and after reversal on neuromuscular blockade will be analyzed in detail.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sugammadex | Sugammadex 200 mg iv, single dose, bolus. |
| DRUG | Neostigmine and glycopyrrolate | Neostigmine 2.5 mg and glycopyrrolate 0,5 mg, iv, single dose, bolus, diluted in 2 ml volume with saline |
Timeline
- Start date
- 2009-04-01
- Primary completion
- 2010-03-01
- Completion
- 2010-03-01
- First posted
- 2010-06-11
- Last updated
- 2010-06-11
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT01142648. Inclusion in this directory is not an endorsement.